Cargando…

The Potential for EBV Vaccines to Prevent Multiple Sclerosis

There is increasing evidence suggesting that Epstein-Barr virus infection is a causative factor of multiple sclerosis (MS). Epstein-Barr virus (EBV) is a human herpesvirus, Human Gammaherpesvirus 4. EBV infection shows two peaks: firstly, during early childhood and, secondly during the teenage years...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maple, Peter A., Ascherio, Alberto, Cohen, Jeffrey I., Cutter, Gary, Giovannoni, Gavin, Shannon-Lowe, Claire, Tanasescu, Radu, Gran, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263514/ https://www.ncbi.nlm.nih.gov/pubmed/35812097 http://dx.doi.org/10.3389/fneur.2022.887794

Ejemplares similares

Editorial: Preventing multiple sclerosis
por: Dobson, Ruth, et al.
Publicado: (2022)

An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination
por: Maple, Peter A. C., et al.
Publicado: (2020)

TLR2 – an innate immune checkpoint in multiple sclerosis
por: Hossain, Md Jakir, et al.
Publicado: (2015)

Predicting Multiple Sclerosis: Challenges and Opportunities
por: Hone, Luke, et al.
Publicado: (2022)

Multiple Sclerosis and Its Treatment
por: Giovannoni, Gavin, et al.
Publicado: (1999)

Attitudes of people with multiple sclerosis toward brain donation
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
por: Morandi, Elena, et al.
Publicado: (2019)

Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey
por: Rinker, John R, et al.
Publicado: (2015)

Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple Sclerosis
por: Yoon, Keejin, et al.
Publicado: (2022)

The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis
por: Morandi, Elena, et al.
Publicado: (2017)

No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis
por: Nixon, Richard, et al.
Publicado: (2014)

Preventing Multiple Sclerosis: The Pediatric Perspective
por: Hardy, Duriel, et al.
Publicado: (2022)

Epidemiology of Multiple Sclerosis: Environmental Factors
por: Ascherio, Alberto, et al.
Publicado: (2010)

Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu, Radu, et al.
Publicado: (2013)

The Global Landscape of EBV-Associated Tumors
por: Shannon-Lowe, Claire, et al.
Publicado: (2019)

Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?
por: Mirabella, Massimiliano, et al.
Publicado: (2022)

Women's Health in Multiple Sclerosis: A Scoping Review
por: Ross, Lindsay, et al.
Publicado: (2022)

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis
por: Amato, Maria Pia, et al.
Publicado: (2022)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
por: Hossain, Md Jakir, et al.
Publicado: (2018)

Increased IL-2 and Reduced TGF-β Upon T-Cell Stimulation are Associated with GM-CSF Upregulation in Multiple Immune Cell Types in Multiple Sclerosis
por: Aram, Jehan, et al.
Publicado: (2020)

Occupational outcomes of people with multiple sclerosis: a scoping review
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2022)

Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis
por: Connick, Peter, et al.
Publicado: (2018)

Comorbidity in Multiple Sclerosis
por: Magyari, Melinda, et al.
Publicado: (2020)

ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK
por: Jacobs, Benjamin M, et al.
Publicado: (2023)

Cognitive Impairment in Multiple Sclerosis With Regards to Disease Duration and Clinical Phenotypes
por: Brochet, Bruno, et al.
Publicado: (2019)

Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
por: Tornatore, Carlo, et al.
Publicado: (2022)

Weighing Evidence from Mendelian Randomization—Early-Life Obesity as a Causal Factor in Multiple Sclerosis?
por: Ascherio, Alberto, et al.
Publicado: (2016)

Intrathecal, Not Systemic Inflammation Is Correlated With Multiple Sclerosis Severity, Especially in Progressive Multiple Sclerosis
por: Milstein, Joshua L., et al.
Publicado: (2019)

Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
por: Aram, Jehan, et al.
Publicado: (2018)

Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis
por: Bruno, Antonio, et al.
Publicado: (2022)

Deciphering Multiple Sclerosis Progression
por: Meca-Lallana, Virginia, et al.
Publicado: (2021)

Editorial: Cognition in Multiple Sclerosis
por: Cortese, Rosa, et al.
Publicado: (2021)

Impact of Andropause on Multiple Sclerosis
por: Ysrraelit, Maria C., et al.
Publicado: (2021)

Therapeutic Advances in Multiple Sclerosis
por: Yang, Jennifer H., et al.
Publicado: (2022)

Microglia in the context of multiple sclerosis
por: Zhang, Xue, et al.
Publicado: (2023)

Fine Particulate Matter Related to Multiple Sclerosis Relapse in Young Patients
por: Januel, Edouard, et al.
Publicado: (2021)

Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient Survey
por: Kamm, Christian P., et al.
Publicado: (2018)

The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative Results
por: Hostenbach, Stéphanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2l0h62nvektbbrruo2rfr933rs